Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials
click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate



Monday, October 5, 2015

NYU Researchers Find Development of Serious Liver Damage in Mid- to Late-adulthood Among People Who Inject Drugs with Untreated Chronic Hepatitis C Infection

October 5, 2015
N-56 2015-16

Few people who inject drugs are engaged in needed care for chronic HCV infection; Early engagement in treatment needs to be a policy priority for these individuals

The Hepatitis C virus (HCV) infection is a chronic blood-borne viral infection that affects an estimated 160 million people, or 2-3% of the population world-wide. Alarmingly, chronic HCV infection accounts for one-quarter of the cases of cirrhosis and hepatocellular carcinoma (HCC). If HCV is left untreated, chronic liver disease will occur in 60–70% of the cases, cirrhosis in 5–20% of the cases, and 1–5% will die from decompensated cirrhosis or HCC.

In most high-income countries, such as the United States, where drug injection is the primary route of HCV transmission, the disease is concentrated among people who inject drugs (PWID). While it is estimated that 50–80% of PWID are chronically infected, fewer than 5% of PWID have received treatment.

In a new study, “Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis,” published in the International Journal of Drug Policy, a team of researchers from New York University’s Center for Drug Use and HIV Research (CDUHR) assessed existing data on the natural history of HCV among PWID. A total of twenty-one studies examined over 8500 PWID, who contributed nearly 120,000 person-years at risk, for the study of four major HCV-related outcomes included in the synthesis.

Read more....

2 comments:

  1. AM SAMFOR, FROM ISLAND, THANKS TO DR ONIHA WHO CURED ME FROM liver chirosis and FATTY LIVER PROBLEM WITH HIS HERBAL MEDICATION. I WAS DIAGNOSED OF FATTY LIVER PROBLEEM FIVE YEARS AGO, I VISITED MEDICAL DIALYSIS CENTER, AND THERE WERE NO BETTER IMPROVEMENT, UNTIL I SAW DR ONIHA'S TESTIMONIES AND RECONMMENDATIONS ONLINE, ON HOW HE HAS BEEN CURING PEOPLE OF LIVER PROBLEMS, AND I DECIDED TO CONTACT HIM, AND HE ADMINISTERED HID DERBAL MEDICATION ON ME, WITHIN A MONTH, I WAS CURED. IN CASE YOU ARE PASSING THROUGH A SIMILAR PROBLEM AND YOU NEED DR ONIHA'S ASSISTANCE, YOU CAN CALL OR WHATSAP +2347089275769 OREMAIL: DRONIHASPELL@YAHOO.COMAM SAMFOR, FROM ISLAND, THANKS TO DR ONIHA WHO CURED ME FROM liver chirosis and FATTY LIVER PROBLEM WITH HIS HERBAL MEDICATION. I WAS DIAGNOSED OF FATTY LIVER PROBLEEM FIVE YEARS AGO, I VISITED MEDICAL DIALYSIS CENTER, AND THERE WERE NO BETTER IMPROVEMENT, UNTIL I SAW DR ONIHA'S TESTIMONIES AND RECONMMENDATIONS ONLINE, ON HOW HE HAS BEEN CURING PEOPLE OF LIVER PROBLEMS, AND I DECIDED TO CONTACT HIM, AND HE ADMINISTERED HID DERBAL MEDICATION ON ME, WITHIN A MONTH, I WAS CURED. IN CASE YOU ARE PASSING THROUGH A SIMILAR PROBLEM AND YOU NEED DR ONIHA'S ASSISTANCE, YOU CAN CALL OR WHATSAP +2347089275769 OREMAIL: DRONIHASPELL@YAHOO.COM

    ReplyDelete
  2. Good health is not something we can buy. However, it can be an extremely valuable savings account.
    Great information. This works great for me. Thanks for sharing this.

    ReplyDelete